Stockreport

Alvotech and Dr Reddy's partner to commercialise AVT03 [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF AVT03 is a biosimilar candidate to the reference products Prolia and Xgeva (denosumab). Prolia and Xgeva are used to treat conditions including osteoporosis in postme [Read more]